Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.51B | $2.18B | $1.97B | $2.20B | $2.29B | $2.29B | $2.25B | $2.46B |
| Cost of revenue | $1.95B | $1.75B | $1.64B | $1.77B | $1.78B | $1.72B | $1.69B | $1.86B |
| Gross profit | $560.00M | $431.00M | $338.00M | $433.00M | $506.00M | $567.00M | $554.00M | $605.00M |
| Gross margin | 22.3% | 19.8% | 17.1% | 19.7% | 22.1% | 24.8% | 24.7% | 24.6% |
| Research and development | $65.00M | $60.00M | $58.00M | $63.00M | $67.00M | $67.00M | $66.00M | $65.00M |
| Selling, general and administrative | $185.00M | $178.00M | $159.00M | $160.00M | $157.00M | $182.00M | $182.00M | $183.00M |
| Operating expenses | $251.00M | $230.00M | $250.00M | $242.00M | $237.00M | $257.00M | $200.00M | $273.00M |
| Operating income | $309.00M | $201.00M | $88.00M | $191.00M | $269.00M | $310.00M | $354.00M | $332.00M |
| Operating margin | 12.3% | 9.2% | 4.5% | 8.7% | 11.8% | 13.5% | 15.8% | 13.5% |
| EBITDA | $442.00M | $341.00M | $273.00M | $340.00M | $409.00M | $445.00M | $493.00M | $489.00M |
| Interest income | $0 | −$52.00M | $0 | — | $0 | −$49.00M | $0 | — |
| Interest expense | −$55.00M | $0 | −$52.00M | −$54.00M | −$53.00M | $0 | −$52.00M | −$49.00M |
| Income before taxes | $256.00M | $136.00M | $12.00M | $134.00M | $169.00M | $253.00M | $297.00M | $280.00M |
| Income taxes | $72.00M | $29.00M | −$93.00M | $87.00M | $29.00M | $70.00M | −$34.00M | $99.00M |
| Net income | $184.00M | $107.00M | $105.00M | $47.00M | $140.00M | $183.00M | $331.00M | $181.00M |
| Net margin | 7.3% | 4.9% | 5.3% | 2.1% | 6.1% | 8.0% | 14.7% | 7.3% |
| EPS, basic | $1.60 | $0.93 | $0.92 | $0.41 | $1.22 | $1.58 | $2.85 | $1.55 |
| EPS, diluted | $1.59 | $0.93 | $0.92 | $0.40 | $1.20 | $1.57 | $2.82 | $1.53 |
| Diluted shares | 115.30M | 115.00M | 114.30M | 115.40M | 116.20M | 116.50M | 117.00M | 117.80M |
Figures describe Eastman Chemical shares, not any token. As of Jul 31, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.